Presentation of a new H-2Dk-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin

Journal of General Virology

Volumn 83, Issue 3, 2002, Pages 641-650

  Lomas, Mehnaaz ^a   Hanon, Emmanuel ^a   Tanaka, Yuetsu ^a   Bangham, Charles R M ^a   Gould, Keith G ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; LACTACYSTIN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; PROTEASOME INHIBITOR; PROTEINASE; TAX PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN TARGETING; VACCINIA VIRUS; VIRUS RECOMBINANT; VIRUS STRAIN;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; MURINAE; RNA VIRUSES; VACCINIA VIRUS; VECTORS;

EID: 0036190728     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-3-641     Document Type: Article

References (49)

1. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides
2. MUC1 peptide epitopes associated with five different H-2 class I molecules
3. HTLV-I infections
4. The cytotoxic T-lymphocyte response to HTLV-I: The main determinant of disease?
5. Genetic control and dynamics of the cellular immune response to the human T-leukaemia virus, HTLV-I
6. Interaction of HTLV-I Tax with the human proteasome: Implications for NF-κB induction
7. The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26 S proteasome
8. Human T-cell leukaemia virus types I and II
9. The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells
10. Vaccinia virus expression vector: Coexpression of β-galactosidase provides visual screening of recombinant virus plaques
11. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: Novel mRNAs and proteins produced by HTLV type I
12. An intracisternal A-particle sequence codes for an antigen recognised by syngeneic cytolytic T lymphocytes on a mouse spontaneous leukemia
13. Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice
14. Mechanistic studies on the inactivation of the proteasome by lactacystin: A central role for clasto-lactacystin β-lactone
15. Genes for Plasmodium falciparum surface antigens cloned by expression in COS cells
16. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin
17. k-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin
18. Structure of 20S proteasome from yeast at 2.4 Å resolution
19. Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime
20. + T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes
21. Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins
22. Proteasome complex as a potential cellular target of hepatitis B virus X protein
23. + cytotoxic T lymphocytes specific for HTLV-IpX in patients with HTLV-I associated neurological disease
24. Specific cytolysis of fresh tumor cells by an autologous killer T cell line derived from an adult T cell leukemia/lymphoma patient
25. + cytotoxic T cells directed against HTLV-I-infected cells
26. Proteasome inhibitors: Valuable new tools for cell biologists
27. Proteasomes can either generate or destroy MHC class I epitopes: Evidence for nonproteasomal epitope generation in the cytosol
28. k-restricted epitope in the middle T protein
29. d through interactions between a glutamine at P3 and pocket D
30. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB
31. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis
32. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously
33. A valid ELISPOT assay for enumeration of ex vivo, antigen-specific, IFNγ-producing T cells
34. SYFPEITHI: Database for MHC ligands and peptide motifs
35. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented by MHC class I molecules
36. HsN3 proteasomal subunit as a target for Human Immunodeficiency Virus type 1 Nef protein
37. Effects on NF-κB1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome
38. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
39. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses
40. HIV-1 Tat inhibits the 20 S proteasome and its 11 S regulator-mediated activation
41. Immunogenicity of human T cell leukemia virus type-I (HTLV-I) antigens for cytotoxic lymphocytes in the rat system
42. k-restricted epitope prominent in primary influenza A virus infection
43. Cytotoxic T lymphocytes recognize fragments of the influenza nucleoprotein
44. Regulation of the 26S proteasome by adenovirus E1A
45. Human T cell leukaemia virus type I (HTLV-I) and human diseases
46. The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors: Involvement of nonproteasomal cytosolic proteases in antigen processing?
47. Cross-recognition of two middle T protein epitopes by immunodominant polyoma virus-specific CTL
48. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses
49. Structural and functional characterization of interaction between Hepatitis B virus X protein and the proteasome complex